Long Term Care Market Will Be Worth $1,255.9 Billion By 2024: Grand View Research, Inc.

The global Long Term Care (LTC) market is expected to reach USD 1,255.9 billion by 2024, according to a new report by Grand View Research, Inc. The market is expected to boom owing to the increasing awareness of people about the different home healthcare facilities, the increasing medical coverage for home healthcare, and the increasing aging population.

In October 2015, there were around 12 million people receiving home healthcare and the number is expected to increase dramatically. Moreover, according to the U.S. Census Bureau, the population aged 65 and older is expected to reach 84 million by 2050 as against 43.1 million in 2012. Moreover, there has been a shift to in-home care from long term care. The nursing homes have shrunk by 350 over the past six years, while the in-home nursing programs have doubled.

U.S. Long Term Care market, by service, 2013 – 2024 (USD Billion)

long-term-care-services-market.png

Browse full research report on Long Term Care Market

Further key findings from the report suggest:

  • In 2015, the home healthcare dominated the market owing to the increasing awareness regarding home healthcare facilities, the cost savings offered by them as compared to hospital stays or nursing homes, and proactive health monitoring. Home healthcare is booming in the developing countries owing to the increasing need for geriatric care, double income households, and social changes. India has many home healthcare startups such as Health Care at Home, Zoctr, Vatsalya, Care24, Zozz, Life Circle Health Services, Healers at Home, and the Nightingales.
  • The hospice care is the fastest growing market owing to the increasing incidence rates of Alzheimer’s and dementia and an increase in the post-hospital care. Moreover, the coverage offered by both the Medicaid and private insurers has relieved the residents from the out-of-pocket payments that have to be borne by them. According to the Hospice Association of America, Medicaid pays USD 601 per day for the inpatient hospice care and USD 789 for 24-hour home care. Moreover, in August 2013, the Palliative Care and Hospice Education and Training Act provided a grant of USD 50 million for the training of doctors and allocating awards for educators in the field.
  • North America dominated the market in 2015. The market for long term care services is majorly driven by the increasing aging population, awareness about the advantages of home healthcare services, and the government support. Around 13% of the people in the U.S. are 65 years or above. By 2050, it is expected that one in five Americans would be at least 65 years of age.
  • Asia Pacific is the fastest growing market owing to the increasing rates of chronic diseases, the increasing disposable incomes, and decreasing working population. For instance, in China, the one-child policy has eventually decreased the working population as compared to the older population. In May 2016, MyCareLine raised USD 526,000 for its alliance with Hoffman World. The Spanish Company provides Hoffman methodology of rehabilitation. The method is commercial in Latin America and Europe. In India, Portea is one of the market leaders in the home healthcare industry. In September 2015, Portea raised USD 37.5 million for investing in better home healthcare facilities.
  • Industry players are continuously investing on expanding and revamping their existing facilities. For instance, in February 2016, Sunrise Senior Living, Inc. started a new facility joining its existing 41 Sunrise communities. The new facility will offer memory care programming, assisted living services, and support to residents in the early stage of memory loss.
  • Major market players are Brookdale Senior Living, Inc., Sunrise Senior Living, Inc., Emeritus Corporation, Atria Senior Living Group, Extendicare, Inc., Gentiva Health Services, Inc., Senior Care Centers of America, Kindred Healthcare, Inc., Genesis Healthcare Corp., and Home Instead Senior Care, Inc.

About Grand View Research, Inc:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

For more information: http://www.grandviewresearch.com

 

Mortuary Equipment Market Growth To Be Driven By Growing Demand For Automation In Mortuary Procedures Till 2025:Grand View Research,inc.

The global mortuary equipment market is expected to reach USD 1.23 billion by 2025, according to a new report by Grand View Research, Inc. Rising demand for automation in mortuary-related procedures, including autopsy, body embalming, shifting, and storage has resulted in technological advancements in these equipment. Growing usage of advanced devices is expected to drive the market during the forecast period.

Rising opportunities in private healthcare sector provide huge scope for increase in the number of hospitals, thus, increasing the number of morgues. In addition, the entry of private morgues, which also offer funeral services, is expected to play an important role in increasing the demand for these equipment during the forecast years. Introduction of technically advanced devices that reduce procedural timings and increase convenience of the professionals is anticipated to drive the market.

In addition, cultural factors, such as funeral traditions, have varying impacts on the market growth. In regions where Christianity is dominant, the demand for private morgue services is high. On the other hand, as per Hindu and Buddhist traditions the dead are cremated; hence, in regions where other religions are prevalent, the usage of morgue, is limited to hospitals.

Browse full research report on Mortuary Equipment Market: http://www.grandviewresearch.com/industry-analysis/mortuary-equipment-market

Further Key Findings from the Study Suggest:

  • The study suggests that refrigeration unit segment captured the largest share in 2016. High demand for the customized storage units and usage of different size refrigeration units for optimizing space are driving growth
  • Huge focus on developing innovative technologies in autopsy devices, including platform and other accessories, used in the procedure
  • Shifting preference of funeral procedures from burial to cremation in order to save costs is expected to hamper the growth rate of embalming workstation segment
  • North America dominated this industry in 2015, with the U.S. capturing the largest share
  • Higher demand for private morgues and faster adoption of advanced technologies are the factors driving growth in this region
  • Asia pacific is expected to exhibit the fastest growth during the forecast period. Growing number of hospitals and emergence of local players are the factors expected to fuel the growth.
  • Few of the major companies operating in the market include Leec Ltd; Roftek Ltd; KUGEL medical GmbH & Co. KG; SM Scientific Instruments Pvt. Ltd.; Thermo Fisher Scientific, Inc.; HYGECO; Mortech Manufacturing Company, Inc.; C.F. di Ciro Fiocchetti & C. s.n.c.; and Mortuary Lift Company.

Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the mortuary equipment market on the basis of product and region:

Mortuary Equipment Product Outlook (Revenue, USD Million 2014 – 2025)

  • Trolleys
  • Refrigeration Units
  • Autopsy Platforms and equipment
  • Embalming Workstation
  • Dissection Table
  • Other Accessories

Mortuary Equipment Regional Outlook (Revenue, USD Million, 2014 – 2025)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
  • Asia Pacific
    • China
    • India
  • Latin America
    • Mexico
    • Brazil
  • MEA
    • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: http://www.grandviewresearch.com

Ventricular Assist Device Market Is Anticipated To Grow Swiftly Due To Increasing Demand For Favorable Reimbursement Policies Till 2022: Grand View Research, Inc.

The global ventricular assist device market is expected to reach USD 1.97 billion by 2022, according to a new report by Grand View Research, Inc. Key factors attributing to its rapid growth include rising prevalence of cardiovascular disorders coupled with the development of technological advanced products such as miniature device with infection reduction technology.

Furthermore, increasing healthcare expenditure, favorable reimbursement policies and advanced technological facilities, are expected to positively reinforce ventricular assist device market growth over the next seven years.

Ventricular assist device market is segmented on the basis of type of product which includes left ventricular, right ventricular and bi-ventricular assist device. Key factors attributing to rapidly increasing number of patients with end stage heart failure and low availability of therapeutic options are among the key factors attributing to the market growth.

With continual shortage of organ donors and increasing demand of LVADs’ for bridge to transplantation in patients suffering from end stage heart failure, is expected to positively reinforce market growth over the forecast period.

Lack of developed reimbursement policies in underdeveloped economies of Africa and Asia is one of the key factors attributing for low penetration of these device. However, constant economic development, improving healthcare infrastructure and reimbursement policies in countries such as India and China is expected to positively reinforce market growth in next seven years.

Technological advancements in VADs have been a continuous process since the launch of first generation device. First generation VADs are referred to as pulsatile volume displacement pumps which are powered by pneumatic or electrical drive systems. Some of the U.S. FDA approved products are the Abiomed BVS5000, Worldheart Novacor System (LVAS).

Second generation ventricular assist device which are usually known as continuous flow LVADs were developed to overcome several limitations of the pulsatile displacement systems. At present, second generation LVADs that are available include the TandemHeart pVAD, Thoratec Heartmate II, Jarvik 2000, and the Impella Pump System.

Third generation ventricular assist device such as VentrAssist, DuraHeart, HeartMate III LVAD and others are currently under various stages of development, clinical trials and commercialization stages. These third generation ventricular assist device are continuous flow device with more advancement in product design, materials, battery capacity and size. Constant development in these devices serves as a high impact rendering driver for the growth of the market.

Browse full research report on Ventricular Assist Device Market: http://www.grandviewresearch.com/industry-analysis/ventricular-assist-devices-market

Further key findings from the report suggest:

  • In 2014, North America accounted for largest market share of over55%. Key factors attributing to its large share include presence of advanced healthcare infrastructure, and high level of collaboration between various stakeholders including medical fraternity, medical device industry, regulatory authorities, universities and others.
  • Furthermore, presence of high research expenditure by public and private entities in healthcare sector is anticipated to propel market growth for ventricular assist device in the coming seven years.
  • Asia Pacific is expected to be one of the fastest growing markets, growing at a CAGR of over17% during the forecast period. Key factors attributed to the growth are high economic growth in countries such as China, Brazil, India, and South Korea coupled with high unmet medical needs is expected to boost usage rates of ventricular assist device.
  • Key players operating in ventricular assist device market include Abiomed, HeartWare International, Thoratec, Inc., Berlin Heart, Cardiac Assist and ReliantHeart

Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the ventricular assist device market on the basis of product and region:

Ventricular Assist device Product Outlook (Revenue, USD Million, 2014 – 2022)

  • Left ventricular assist device
  • Right ventricular assist device
  • Bi-ventricular assist device

Ventricular Assist device Regional Outlook (Revenue, USD Million, 2014 – 2022)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
    • Mexico
  • MEA
    • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: http://www.grandviewresearch.com

Pharmaceutical Robots Market Is Predicted To Grow Swiftly Due To Increasing Drug Discovery & Clinical Trials Till 2025: Grand View Research, Inc.

The global pharmaceutical robots market is anticipated to reach USD 430.0 million by 2025, according to a new report by Grand View Research, Inc. This growth can be attributed to the flourishing pharmaceutical industry.

The pharmaceutical industry is flourishing due to huge R&D investments by global players. With increasing drug discovery and clinical trials, there is growing demand for robotics. To minimize workload and maintain higher levels of accuracy, automation has become a significant part of pharmaceutical manufacturing. It increases efficiency, prevents performance of repetitive activities, and avoids human error & contamination.

Technological advancement is an important factor driving growth. The use of robots & automated machines in the field of pharmaceuticals is still in its nascent stage and expected to grow in the near future. The automation industry has incorporated a few new techniques such as collaborative robots and laboratory automation.

Pharmaceutical robotic machines also minimize manufacturing costs by reducing labor. These machines are 3 to 4 times faster than humans and have the capacity to work for 24 hours. Reduction in production cost is expected to raise return on investment in the long run, thus driving demand for these products in the future.

Japan pharmaceutical robots market, by product, 2014 – 2025 (USD Million)

Browse full research report on Pharmaceutical Robots Market

Further key findings from the report suggest:

  • In 2016, traditional robots held the largest share due to their availability in different types, varied applications, and increased awareness
  • Collaborative robots are expected to witness highest growth over the forecast period owing to their ability to easily integrate with existing manufacturing environments and interact with humans
  • Picking and packaging segment dominated the market in 2016 since almost all types of robotic machines are primarily used for picking and packaging
  • Laboratory applications are anticipated to propel significant growth over the forecast period due to increasing laboratory automation and the need to reduce the risk of human contamination
  • Pharmaceutical companies were the biggest contributors to the growth of the market in 2016 owing to a growing number of new drug development and clinical trials
  • Asia Pacific dominated the market in 2016 and is also anticipated to be the biggest driver of growth due to high penetration of robotic machines in pharma companies in countries such as China and Japan
  • Some of the key players include FANUC America Corporation; Kawasaki Heavy Industries, Ltd.; ABB Ltd.; Seiko Epson Corporation; Denso Wave Inc.; Yaskawa Electric Corporation; Universal Robots A/S; and Marchesini Group S.p.A.

 About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

 For more information: http://www.grandviewresearch.com

 

Hemostasis & Tissue Sealing Agents Market Is Projected To Grow Due To Rapid Growth Of Minimal Invasive Technology Till 2022: Grand View Research, Inc.

The global hemostasis and tissue sealing agents market is expected to reach USD 7.4 billion by 2022, according to a new report by Grand View Research Inc. The global hemostasis and tissue sealing agents market has gained popularity over time due to its ability in preventing blood loss. Rapid growth of minimal invasive technology and rising demand for faster recovery by patients is expected to promote market growth over the forecast period.

According to the CDC, approximately 150 million of American population is currently suffering with at least one chronic condition, which leads to surgeries and even mortality at times. An estimate over the rising incidence was made by the CDC, which concluded that over 48% of the entire American population is expected to suffer by chronic condition.

The demand for wound management is expected to rise with increasing chronic disease incidence over the next seven years. The Public Health Agency of Canada in its report stated that the chronic disease occurrence rate is anticipated to increase by 14% annually and four out of five cases are of high risk requiring immediate treatment and surgeries.

North America hemostasis and tissue sealing agents market, by technology, 2012-2022, (USD Million)

hemostasis-tissue-sealing-agents-market.png

Browse full research report on Hemostasis And Tissue Sealing Agents Market

Further key findings from the report suggest:

  • The hemostats market is expected to grow at a CAGR of over9.0% over the forecast period owing to, the rise in global volume of surgeries and increased applicability across a variety of surgeries. The products avoid occurrence of hypovolemic shock, thrombocytopenia, blood transfusions, and increase in post-operative complications.
  • Flowable hemostats are a combination of active and mechanical agents. They function by blocking blood flow and also convert fibrinogen into fibrin for the coagulation process to commence. This segment is expected to grow at a lucrative CAGR of over 10.0% from 2015 to 2022.
  • North America is estimated to be the largest market for the hemostasis and tissue sealing agents over the forecast period and is expected to account for over 30.0% share by 2022.
  • Asia Pacific is identified as a lucrative market due to a rapid growth in the surgery volume brought about by the introduction of medical tourism. It is anticipated to account for over 27.0% of the overall market share by 2022. The Europe hemostasis and tissue sealing agents market is expected to be driven by the rise in geriatric population base, which is expected to ultimately lead to a surge in procedure volume.
  • Some key players of this market include Johnson & Johnson, CryoLife Inc, Pfizer, C R Bard, B Braun, Covidien, and Smith & Nephew.
  • Market participants are involved in technological advancements in order to ensure sustainability and improve regional presence.
  • For instance, in March 2015, Ethicon announced higher efficiency of EVARREST fibrin sealant patch as compared to its substitute, TachoSil patch (Baxter). Further study would be conducted at the St. Vincent Heart Centre of Indiana to understand added advantages that the product can offer.
  • In August 2015, Integra Life Sciences announced a new application of the Integra Dermal Regeneration Template in chronic diabetes-based foot ulcers. The product is expected to be used for treating these ulcers post its approval by the FDA in 2016.

 For more information: http://www.grandviewresearch.com

Hemodynamic Monitoring Devices Market Is Projected To Witness Growth Based On The Increasing Incidences Of Lifestyle-Related Conditions Like Diabetes, Obesity, Stroke & Hypertension Till 2024:Grand View Research, inc.

The global hemodynamic monitoring devices market is expected to reach USD 1.4 billion by 2024, according to a new report by Grand View Research, Inc. The increasing demand for non-invasive monitoring techniques coupled with the rising prevalence of chronic illness is expected to drive the market over the forecast period.

The hemodynamic monitoring market is influenced by new technologies such as echocardiography, thoracic electrical bio-impedance and others that maybe used to non-invasively monitor parameters such as cardiac output, arterial pressure, blood oxygen level, and central venous pressure.

Furthermore, the rising population of critically ill patients coupled with defective healthcare facilities with drawbacks, such as understaffing, is propelling market players to develop minimal invasive hemodynamic monitoring devices that may be used in clinical and home care settings. Along with the new product development, the market is also anticipated to witness the development of technologies that help in the early diagnosis of shock and sepsis.

Furthermore, efforts by key industry players to understand critical illnesses at molecular levels leading to the development of efficient assessment products are expected to be witnessed over the forecast period. Hence, all these company strategies and the research conducted are eventually expected to promote market growth over the forecast period.

North America Hemodynamic Monitoring Devices Market share, by product, 2014 – 2024 (USD Million)

hemodynamic-monitoring-devices-market.png

Browse full research report on Hemodynamic Monitoring Devices Market

Further key findings from the report suggest:

  • The disposables segment is anticipated to be the largest segment by 2024. The rising sale of hemodynamic monitoring systems and increasing applications of these systems in home care settings, hospitals, and clinics are expected to boost the segment growth.
  • The non-invasive devices segment is expected to be the fastest growing hemodynamic monitoring market. Risks that include the development of arrhythmias due to the use of pulmonary artery catheter and the development of other methodologies that measure the cardiac output, such as echocardiographs, are the vital impact rendering drivers.
  • Asia Pacific is anticipated to be the fastest growing regions and is anticipated to contribute to about 20.0% of the global revenue by 2024. The strengthening of the distribution channels by companies and the registration of products in countries, such as China, India, Australia, and others, are expected to support the growth over the forecast period. For instance, LiDCO Group, in their 2016 prelim report emphasized on its strategy of appointing new distributors for the Australian and South East Asian region.
  • Major industry players are Edward Lifesciences, LiDCO Group Plc, Deltex Medical, Philips Medical, GE Healthcare, Noninvasive Medical Technologies, Inc., Tensys Medical, Inc., Cardio-Dynamics International, and Drager Medical, Inc. As mentioned above, the new product development is expected to drive the market over the forecast period.
  • For instance, in March 2016, the LiDCO Group received the U.S. FDA approval for the LiDCO unity and launched the product in the European region. Along the same time, LiDCO also succeeded in registering itself in China to explore untapped territories and increase their global presence.

 For more information: http://www.grandviewresearch.com

Hemodialysis And Peritoneal Dialysis Market Will Reach 108.5 Billion By 2025: Grand View Research, Inc.

The global hemodialysis and peritoneal dialysis market is expected to reach USD 108.5 billion by 2025, according to a new report by Grand View Research, Inc. Home-based dialysis treatment is anticipated to witness lucrative growth over the forecast period. Factors supporting this trend include; increasing development of small and automated products capable of providing treatment at home, rising number of individuals requiring daily procedures, growing number of individuals aptly trained to perform self-treatment, and initiatives by market participants toward raising education and training for home dialysis performance.

This industry is highly competitive with a few players holding relatively high proportion of the market share. However, the dominance of each player is in a separate region thereby limiting direct competition. For instance, Baxter generates higher revenue in Europe whereas Fresenius Medical Care AG & Co. KGaA gains higher revenue in the U.S. This scenario is anticipated to change over the forecast period owing to increasing globalization, and efforts by companies to expand their revenues and profits.

U.S. hemodialysis and peritoneal dialysis market, by product, 2014-2025 (USD Million)

us-hemodialysis-and-peritoneal-dialysis-market.png

Browse full research report on Hemodialysis And Peritoneal Dialysis Market

Further key findings from the report suggest:

  • Hemodialysis dominates the industry with over 80.0% of the market share. These processes are performed in centers as well as in home settings primarily for adults. This enhanced applicability and benefits in comparison to peritoneal dialysis are expected to promote growth.
  • Presence of treatment centers and skilled personnel in abundance to carry out procedures is expected to drive the growth for these services. Factors responsible for higher market share of services may be classified into rising number of centers, development of training courses for home-based patients, and rising number of patients requiring dialysis treatment.
  • Home-based procedures are anticipated to witness the fastest growth over the forecast period. Development of small & portable systems along with with rising healthcare literacy amongst patients are vital impact rendering drivers.
  • Regionally, Asia Pacific is predicted to contribute higher revenue share over the forecast period. Improving healthcare infrastructure, rising disposable income, and growing incidence of conditions such as diabetes within the region are expected to support growth.
  • Players highlighted in the study include Fresenius Medical Care AG & Co. KGaA, NIPRO Medical Corporation, B. Braun Avitum AG, Baxter, and DaVita Inc. These companies are aggressively working toward purchasing dialysis centers or establishing new centers to cater to the rising demand.

 For more information: http://www.grandviewresearch.com